Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02454270 |
Title | A Dose Escalation Study of JNJ-64052781 in Participants With Relapsed or Refractory B-cell Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ISR | FRA | ESP | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Detroit | Michigan | United States | Details | |||
New York | New York | United States | Details | |||
Columbus | Ohio | United States | Details | |||
Philadelphia | Pennsylvania | United States | Details | |||
Nashville | Tennessee | United States | Details | |||
Houston | Texas | United States | Details | |||
Edegem | Belgium | Details | ||||
Leuven | Belgium | Details | ||||
Wilrijk | Belgium | Details | ||||
Lille | France | Details | ||||
Pierre Benite | France | Details | ||||
Rennes | France | Details | ||||
Tours Cedex | France | Details | ||||
Haifa | Israel | Details | ||||
Jerusalem | Israel | Details | ||||
Ramat Gan | Israel | Details | ||||
Tel Aviv | Israel | Details | ||||
Barcelona | Spain | Details | ||||
Madrid | Spain | Details | ||||
Salamanca | Spain | Details |